Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alexion
Pharma
FDA expands AZ's Ultomiris to NMOSD after prior rejection
AstraZeneca had to fight off a prior FDA complete response letter to get Ultomiris its NMOSD nod.
Angus Liu
Mar 25, 2024 10:31am
AZ's newest PNH med Voydeya approved in Japan
Jan 19, 2024 11:06am
Alexion inks $125M deal to resolve investor lawsuit
Sep 14, 2023 11:41am
AZ's Ultomiris expansion plan delayed by FDA rejection
Sep 6, 2023 10:37am
SEC charges former Alexion VP Joseph Dupont with insider trading
Jun 30, 2023 8:40am
AZ's bleeding reversal agent Andexxa meets trial endpoint early
Jun 5, 2023 1:53pm